As of 2025-07-07, the Relative Valuation of Sam-A Pharm Co Ltd (009300.KQ) is 37,055.77 KRW. This relative valuation is based on P/E multiples. With the latest stock price at 17,880.00 KRW, the upside of Sam-A Pharm Co Ltd based on Relative Valuation is 107.2%.
The range of the Relative Valuation is 29,170.65 - 48,319.49 KRW.
| Range | Selected | |
| Trailing P/E multiples | 9.8x - 16.2x | 13.6x |
| Forward P/E multiples | 12.2x - 15.5x | 13.8x |
| Fair Price | 29,170.65 - 48,319.49 | 37,055.77 |
| Upside | 63.1% - 170.2% | 107.2% |
| Date | P/E |
| 2025-07-04 | 5.99 |
| 2025-07-03 | 5.96 |
| 2025-07-02 | 5.88 |
| 2025-07-01 | 5.86 |
| 2025-06-30 | 5.87 |
| 2025-06-27 | 5.88 |
| 2025-06-26 | 5.91 |
| 2025-06-25 | 5.95 |
| 2025-06-24 | 5.90 |
| 2025-06-23 | 5.86 |
| 2025-06-20 | 5.93 |
| 2025-06-19 | 5.87 |
| 2025-06-18 | 5.90 |
| 2025-06-17 | 5.87 |
| 2025-06-16 | 5.88 |
| 2025-06-13 | 5.94 |
| 2025-06-12 | 6.00 |
| 2025-06-11 | 5.95 |
| 2025-06-10 | 5.92 |
| 2025-06-09 | 5.88 |
| 2025-06-05 | 5.86 |
| 2025-06-04 | 5.83 |
| 2025-06-02 | 5.79 |
| 2025-05-30 | 5.83 |
| 2025-05-29 | 5.78 |
| 2025-05-28 | 5.71 |
| 2025-05-27 | 5.65 |
| 2025-05-26 | 5.67 |
| 2025-05-23 | 5.72 |
| 2025-05-22 | 5.75 |
| 2025-05-21 | 5.65 |
| 2025-05-20 | 5.64 |
| 2025-05-19 | 5.70 |
| 2025-05-16 | 5.71 |
| 2025-05-15 | 5.74 |
| 2025-05-14 | 5.79 |
| 2025-05-13 | 5.75 |
| 2025-05-12 | 5.74 |
| 2025-05-09 | 5.78 |
| 2025-05-08 | 5.75 |
| 2025-05-07 | 5.70 |
| 2025-05-02 | 5.70 |
| 2025-04-30 | 5.67 |
| 2025-04-29 | 5.67 |
| 2025-04-28 | 5.68 |
| 2025-04-25 | 5.64 |
| 2025-04-24 | 5.62 |
| 2025-04-23 | 5.55 |
| 2025-04-22 | 5.52 |
| 2025-04-21 | 5.52 |